Effect of acute and chronic lead exposure on apomorphine-induced sniffing in rats

Pharmacology and Toxicology

Volumn 92, Issue 2, 2003, Pages 88-93

  Fazli Tabaei, Soheila ^a   Fahim, Mohammad ^a   Zarrindast, Mohammad Reza ^b  

^a UNIVERSITY OF DELHI   (India)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LEAD ACETATE; SULPIRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LEAD POISONING; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SNIFFING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; LEAD POISONING; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE;

ANIMALIA;

EID: 0037294905     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920205.x     Document Type: Article

References (35)

1. Braun, A. R. & T. N. Chase: Obligatory D-1 and D-2 receptot interaction in the generation of dopamine agonist related behaviours. Eur. J. Pharmacol. 1986, 131, 301-306.
2. Bressler, J. P & G. W. Goldstein: Mechanism of lead neuro-toxicity. Biochem. Pharmacol. 1991, 41, 479-484.
3. Cooper, G. P, J. B. Suszkiw & R.S. Manalis: Heavy metals: effects on synaptic transmission. Neuropharmacology 1984, 5, 247-266.
4. Cory-Slechta, D. A., M. J., Pokora, R. A. Fox & D. J. O'Mara:. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training. Neurotoxicology 1996, 17, 445-457.
5. Cory-Slechta, D. A & D. V. Widzowski: Low level lead exposure increses sensitivity to the stimulus properties of dopamine D1 and D2 agonists. Brain Res. 1991, 553, 65-74.
6. Ghazi-Khansari, M., N. Rezvani, S. H. Bani-Assadi & M. R. Zarrindast: The effect of lead exposure on licking and yawning behaviour in rats. Pharmacology & Toxicology 1998, 83, 120-124.
7. Hyttel, J.: SCH 23390 the first selective dopamine antagonist. Eur. J. Pharmacol. 1983, 91, 153-154.
8. Hyttel, J.: Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390. Neuropharmacology 1984, 23, 1395-1401.
9. Kala, S. V. & A. L. Jadhav: Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. Neurotoxicology 1995, 16, 297-308.
10. Kazantzis, G.: Lead :ancient metal-modern? In: Lead exposure and child development. An international assessment. Eds.: M. A. Smith, L. D. Grant and A. I. Sors. Kluwer, Dordrecht, 1989, p119.
11. Komulainen, H. & J. Tuomisto: Effects of heavy metals on monoamine uptake and release in brain synaptosomes and blood platelets. Neurobehav. Toxicol. Teratol. 1982, 4, 647-649.
12. Luthman, J., E. Lindqvist, G. A. Gerhardt, L. Olson & B. H. Hoffer: Alterations in central monoaamine systems after postnatal lead acetate treatment in rats. Environ Res. 1994, 65, 100-118.
13. McDougall, S. A., T. F. Arnold & A. J. Nonneman: Ontogeny of locomotor activity and grooming in the young rat:role of dopamine D1 and D2 receptors. Eur. J. Pharmacol. 1990, 186, 223-230.
14. Minnema, D. J., R. D. Greenland & I. A. Michaelson: Effect of in vitro inorganic lead on dopamine release from superfused rat striatal synaptosomes. Toxicol. Appl. Pharmacol. 1986, 84, 400-411.
15. Molloy, A. G. & J. L. Waddington: Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: Differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopromide. Eur. J. Pharmacol. 1985, 108, 305-308.
16. Moorhouse, S. R., S. Carden, P. Drewitt, B. P. Eley, R. J. Hargreaves & D. Pelling: The effect of chronic low level lead exposure on blood-brain barrier function in the developing rat. Biochem. Pharmacol. 1988, 23, 4539-4547.
17. Moresco, R. M., R. Dall'Olio, O. Gandolfi, S. Govoni, S. Di Giovine & M. Trabucchi: Lead neurotoxicity,a role for dopamine receptors. Toxicology 1988, 53, 315-322.
18. Nolan, C. V. & Z. A. Shaikh: Lead nephrotoxicity and associated disorder: biochemical mechanisms. Toxicology 1992, 73, 127-146.
19. Onali, P., M. C Olianas & G. L. Gessa: Selective blockade of dopamine D1 receptors by SCH23390 discloses striatal dopamine D1 receptors mediating the inhibition of adenylate cyclase in rats.Eur. J. Pharmacol. 1984, 99, 127-128.
20. Robertson, G. S. & H. A. Robertson: Synergic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brain Res. 1986, 384, 387-390.
21. Simons, T. J. B.: Cellular interactions between lead and calcium. Brit. Med. Bull. 1986, 42, 431-434.
22. Snyder, S. H.: The dopamine connection. Nature 1990, 347, 121-122.
23. Sokoloff, P., B. Giros, M. P. Matres, M. L. Bouthenet & J. C. Schwartz: Molecular clonning and characterization of a novel dopamine receptor D3 as a target for neuroleptic. Nature 1990, 347, 146-151.
24. Stoof, J. C. & J. W. Kebabian: Opposing roles for D1 and D2 receptors in efflux of cyclic AMP from rat neostriatum. Nature 1981, 294, 366-368.
25. Stool, J. C. & J. W. Kebabian: Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1984, 35, 2281-2296.
26. Takeuchi, Y., K. Fukunaga & E. Miyamoto: Activation of nuclear Ca2+/calmodulin-dependent protein kinase II and brain-derived neurotrophic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells. J. Neurochem. 2002, 82, 316-328.
27. Van Ree, J. M. & G. Wolternik: Injection of low doses of apomorphine in to nucleus accumbens of reduces locomotor activity. Eur. J. Pharmacol. 1981, 72, 107-111.
28. Van Wimersma Greidanus, T. B., C. Maigret, M. Torn, E. Ronner, S. Van der Kracht, N. J. A. Van der Wee & D. H. G. Versteeg: Dopamine D1 and D2 receptor agonists and antagonists and neuropeptide-induced excessive grooming. Eur. J. Pharmacol. 1989, 173, 227-231.
29. Waddington, J. L. & K. M. O'Boyle: Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol. Therap. 1989, 43, 1-52.
30. Winder, C. & I. Kitchen: Lead neurotoxicity: a review of biochemical, neurochemical and drug-induced behavioural evidence. Prog. Neurobiol. 1984, 22, 59-87.
31. Zarrindast, M. R., S. Fazli-Tabaei, S. Semnanian, Y. Fathollahi & S. H. Yahayvi: Effects of Adrenoceptor agents on apomorphine-Induced licking behaviour in rats. Pharmacol. Biochem. Behav. 2000, 65, 275-279.
32. Zarrindast, M. R. & H. Naghashi: Bromocriptine requires D1 receptor stimulation for the expression of sniffing behaviour in rats. J. Psychopharmacol. 1991, 5, 160-165.
33. Zarrindast, M. R., M. R. Hodjati, A. Pejhan & E. Soleimannejad: Bupropion induces sniffing: a possible dopamuinergic mechanism. Eur. Neuropsychopharmacol. 1996, 6, 299-303.
34. Zarrindast, M. R. & M. Poursoltan: Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine. Brit. J. Pharmacol. 1989, 96, 843-848.
35. Zuch, C. L., D. J. O'Mara & D. A. Cory-Stechta: Low-level lead exposure selectivity enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. Toxicol. Appl. Pharmacol. 1998, 150, 174-185.